Published in Oncogene on May 02, 2016
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology (2007) 26.78
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 8.04
AP-1 in cell proliferation and survival. Oncogene (2001) 6.07
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet (2013) 3.87
Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol (2000) 3.86
A comprehensive survey of Ras mutations in cancer. Cancer Res (2012) 3.67
Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab (2014) 2.35
ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell (2014) 2.31
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest (2008) 2.26
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol (2012) 2.25
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer (2007) 2.23
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet (2005) 2.22
RAS Interaction with PI3K: More Than Just Another Effector Pathway. Genes Cancer (2011) 2.12
Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol (2003) 2.10
Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology (2010) 2.00
Acyl-coenzyme A:cholesterol acyltransferases. Am J Physiol Endocrinol Metab (2009) 1.85
Focal adhesions: structure and dynamics. Biol Cell (2000) 1.71
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer (2011) 1.31
Role of RAS in the regulation of PI 3-kinase. Curr Top Microbiol Immunol (2010) 1.27
Downregulation of gap junctions in cancer cells. Crit Rev Oncog (2006) 1.20
Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta (2004) 1.19
Carboxyl ester lipase: structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis. J Lipid Res (2002) 1.18
Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer (2012) 1.15
Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer (2012) 1.09
Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro. Hepatology (2010) 1.05
Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver. Diabetes (2012) 1.00
Chemokine signaling in inflammation. Crit Care Med (2000) 0.95
Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro. J Pathol (2013) 0.91
Nonalcoholic fatty liver disease in Asia: a story of growth. J Gastroenterol Hepatol (2013) 0.91
MAPKs and signal transduction in the control of gastrointestinal epithelial cell proliferation and differentiation. Int J Mol Sci (2013) 0.87
GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies. Endocr Rev (2012) 0.87
Carboxyl ester lipase cofractionates with scavenger receptor BI in hepatocyte lipid rafts and enhances selective uptake and hydrolysis of cholesteryl esters from HDL3. J Biol Chem (2004) 0.83
Adenovirus RIDα uncovers a novel pathway requiring ORP1L for lipid droplet formation independent of NPC1. Mol Biol Cell (2013) 0.82
Chemokine-based immunotherapy: delivery systems and combination therapies. Immunotherapy (2012) 0.81
Store-operated calcium channels and pro-inflammatory signals. Acta Pharmacol Sin (2006) 0.81
Signalling: the calcium connection. Nat Rev Cancer (2010) 0.79
REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene (2016) 0.78
Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway. Oncogene (2015) 0.78
Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma. Oncogenesis (2016) 0.75
p53R2 Overexpression in Cervical Cancer Promotes AKT Signaling and EMT, and Is Correlated with Tumor Progression, Metastasis and Poor Prognosis. Cell Cycle (2017) 0.75